Setopen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Setopen

Quick Facts about Setopen

Property Description
Active ingredient Acetaminophen (Paracetamol)
Form Oral Tablet (various types) and Suspension
Pharmacological class Analgesic and Antipyretic
Common use Relief of pain and fever
Origin Synthetic (chemically produced)
Status Typically Over-the-Counter (OTC)

What Type of Medicine is Setopen and What is its Main Goal?

Setopen is a brand-name medicine whose single active ingredient is Acetaminophen, also internationally known as Paracetamol (INN). It is classified as an analgesic and antipyretic, meaning its two main functions are to ease pain and reduce high body temperature. Setopen is often positioned as a fast-acting choice for general relief.

Its general goal is to provide symptomatic relief for routine discomforts, such as the aches and elevated body temperature accompanying a cold. The effectiveness of Acetaminophen for managing mild-to-moderate pain and fever is clinically recognized and supported by extensive pharmacological studies. This conclusion highlights why the medicine is frequently chosen for managing common everyday discomfort. Setopen is typically available Over-the-Counter (OTC).


What is the Composition and Form of Setopen?

Setopen is a single-ingredient product derived from a synthetic compound manufactured in a laboratory. The brand typically offers its product line in several oral dosage forms, including standard and extended-release tablets, and a flavored liquid suspension specifically formulated for pediatric use. This focused pediatric option is a key differentiating factor.

Acetaminophen's role as a centrally acting non-opioid analgesic is confirmed by regulatory bodies. The medicine is taken via the oral route of administration and the availability of child-friendly forms ensures dosage precision for younger patients who have difficulty swallowing solids. The Setopen brand maintains the core composition of the active ingredient while offering varied product formats targeting specific age groups and relief needs.

What side effects are possible with Setopen?

Possible Side Effects and Safety Information

The safety profile of Setopen is formally documented by regulatory authorities, classifying adverse reactions by frequency and the body system affected (System-Organ Class or SOC). This ensures patients and healthcare providers can distinguish between common and serious risks.


Adverse Reactions by Frequency

Adverse reactions are classified according to the official documentation:

Classification Examples of Reactions
Very Common (1/10) Nausea, Dizziness
Common (1/100 to < 1/10) Headache, Diarrhoea, Somnolence
Rare (1/10,000 to < 1/1,000) Angioedema, Hepatic Enzyme Elevation

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight rare but clinically important events and specific constraints:

  • Serious Adverse Reactions: Officially listed serious events include Serotonin Syndrome, Agranulocytosis, and potentially severe reactions such as Hepatotoxicity or Severe Cutaneous Adverse Reactions (SCARs).
  • Time- or Duration-Related Patterns: The incidence of reactions like dizziness and nausea is documented as being higher during the first two weeks of treatment initiation. Long-term use is associated with a low, persistent risk of bone fracture.
  • Population-Specific Safety: Use is officially contraindicated in severe hepatic impairment. In severe renal impairment, increased systemic exposure of metabolites is documented. Furthermore, use during the third trimester of pregnancy may lead to neonatal withdrawal symptoms.
  • Safety Restrictions: Concomitant use with MAOIs is contraindicated. The drug may cause dose-dependent QT interval prolongation, and baseline and periodic monitoring of serum electrolytes is required due to the documented risk of hyponatremia.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Setopen based on severe central nervous system (CNS) and respiratory depression. This information establishes the critical signs of toxicity and the required immediate emergency response.

Documented Overdose Presentations

Symptoms and signs listed in authorized regulatory information include:

  • Profound Somnolence: Extreme sleepiness or inability to be fully aroused (coma).
  • Respiratory Compromise: Slowed or shallow breathing, potentially leading to respiratory arrest.
  • Miosis: Pinpoint pupils.
  • Circulatory Signs: Low blood pressure (hypotension) and a slow heart rate (bradycardia).
  • Cyanosis: Bluish discoloration of the skin, lips, or nail beds.

Emergency Response and Monitoring

Immediate medical help is required in the event of a known or suspected Setopen overdose. Urgent medical attention must be sought without delay upon observing slow breathing or unresponsiveness.

Official management procedures include the administration of a specific opioid antagonist, such as naloxone, to reverse respiratory depression. Following initial treatment and antagonist use, patients must be continuously monitored for an extended period, especially with long-acting formulations, to address the risk of respiratory depression recurring.

Therapeutic Uses of Setopen

The medicine containing acetaminophen is used to address symptoms related to physical discomfort and systemic imbalance. The medication is commonly used to help with the management of mild-to-moderate pain and the reduction of fever in both adult and pediatric patients.


Easing Pain and Acute Discomfort Symptoms

Setopen is commonly used to help address symptom clusters related to physical discomfort, including tension headaches, muscular aches, toothaches, and discomfort from menstrual cramps. It is applied across therapeutic domains where short-term symptomatic assistance is needed, such as when symptoms cluster with colds and influenza. This supportive action assists with maintaining functional stability during episodes of heightened discomfort.

Reducing Fever and Managing Systemic Symptoms

The medicine is also commonly applied in contexts involving symptoms related to systemic imbalance, such as fever. Providing support that helps ease the overall symptom load, it is considered relevant when symptoms interfere with routine activities. Setopen offers symptomatic relief that assists patients, including children and pregnant individuals, during episodes of increased distress or discomfort.


Quick Fact: Support for Symptoms that Interfere with Daily Functioning
Primary Symptoms Symptoms related to physical discomfort and systemic imbalance.
Common Uses Conditions presenting with episodic manifestations like headaches, muscle aches, toothaches, menstrual cramps, and systemic aches of cold/flu.
Therapeutic Benefit Supports the patient by easing the overall symptom load and promoting comfort.

Eligibility and Restrictions for Use

Official Eligibility Rules for Setopen (Acetaminophen)

Regulatory documents define specific populations who are permitted to use Setopen and those who are prohibited or require caution. Use is contraindicated for individuals with a known hypersensitivity to the active ingredient or its components, or for patients with severe hepatic impairment or severe active liver disease. Prior severe skin reactions following Acetaminophen use also constitute an absolute contraindication.

Setopen is approved for use in adults and adolescents. For the geriatric population, no overall differences in safety or effectiveness are observed. While approved for pediatric patients, effectiveness for acute pain in patients younger than 2 years is not established for certain formulations, and specific dosage strengths may be not recommended for young children due to unsuitable strength.

Use requires caution and is conditional in patients with severe renal impairment (creatinine clearance le 30 mL/min), or those with chronic alcoholism or chronic malnutrition. During pregnancy and lactation, use is generally permitted if clinically necessary, under the condition that the lowest effective dose is used for the shortest possible duration.

What should I know about interactions with other medicines?

Setopen, which is a triptan medication, can interact with various other drugs and substances, potentially altering its effects or increasing the risk of adverse reactions. It is crucial to inform your healthcare provider of all prescription and over-the-counter medications, as well as any herbal products or supplements you are currently taking.

Serious Interactions

The most clinically significant interaction involves other medications that affect serotonin levels in the brain. Taking Setopen concurrently with any of the following may lead to a rare but serious condition called Serotonin Syndrome, which requires immediate medical attention:

  • Antidepressants such as Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs).
  • Other Triptans.
  • Monoamine Oxidase Inhibitors (MAOIs).
  • Certain Opioid pain medications and cough medicines.
Type of Interaction Examples of Interacting Substances Potential Effect
Increased Risk of Serotonin Syndrome SSRIs, SNRIs, MAOIs, other triptans Confusion, agitation, muscle twitching, rapid heart rate, severe changes in blood pressure

Other Notable Interactions

Co-administration of Setopen with other Central Nervous System (CNS) depressants (e.g., alcohol, benzodiazepines, other sedatives) may increase the risk of sedation and drowsiness. Additionally, certain medications that interfere with the breakdown of Setopen in the liver can increase its concentration in the blood, potentially leading to increased side effects. These include some antifungal and antibiotic medications. Consult your pharmacist for a complete review of your medication regimen.

Mechanism of Action

The mechanism of action for Setopen (Acetaminophen) centers on its highly selective engagement with core regulatory systems within the Central Nervous System (CNS) to modulate nociceptive signaling and thermoregulatory activity.


Central Inhibition of Prostaglandin Synthesis

This mechanistic domain involves the drug acting as an inhibitor on Cyclooxygenase (COX) enzymes primarily located in the hypothalamus, the brain's thermoregulatory center. By reducing the local synthesis of Prostaglandin E2 ( PGE2), this mechanism physiologically effects a reduction in the hypothalamic setpoint, which engages heat-dissipating responses.

Modulation of Central Pain Pathways

This action involves the drug and its metabolite, AM404, engaging multiple systems, including indirect modulation of Cannabinoid ( CB1) receptors and activation of TRPV1 receptors in the CNS. This multifaceted engagement augments descending nociceptive control pathways, resulting in modified central processing and reduced efferent transmission of nociceptive input at the spinal dorsal horn.


Mechanistic Constraint: CNS Selectivity

  • The drug's mechanism is physiologically limited by its stronger efficacy in the low-peroxide environment of the CNS. Consequently, the mechanism does not significantly inhibit COX enzymes in the high-peroxide environment of peripheral sites of injury, resulting in minimal action against the biological processes that drive local swelling and inflammation.

Dosage and Administration Information

Administration Scope

Feature Official Guideline
Route of Administration Oral (tablets, liquid), Intravenous (IV) Infusion, and Rectal (suppository).
Standard Adult Dose 650 mg to 1000 mg (1 g) per dose.
Maximum Total Daily Dose Must not exceed 4000 mg (4 g) from all combined sources in 24 hours.

Frequency, Timing, and Special Conditions

Setopen is generally administered on an interval-based schedule, most commonly every 4 to 6 hours for immediate-release forms, with a minimum interval of 4 hours between doses. The medicine can be taken with or without food. Extended-release tablets must be swallowed whole and must not be chewed or crushed, as specified in the labeling. Intravenous formulations must be administered as a slow infusion over 15 minutes.

For pediatric patients and individuals weighing less than 50 kg, the dose is determined based on body weight (e.g., 10 mg/kg to 15 mg/kg per dose). Liquid forms must be carefully measured using the dosing device provided with the product. If a regular dose is missed, it should be taken as soon as remembered, unless the next dose is due shortly, in which case the missed dose should be skipped; a double dose must not be taken.

These standard instructions establish a precise, time-controlled protocol, governing administration frequency and setting the absolute maximum threshold to ensure standardized use of the medication.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Setopen

1. Evidence for Symptomatic Relief of Mild-to-Moderate Pain

The active ingredient in Setopen was evaluated in research contexts involving fluctuating or unstable symptoms across numerous clinical research scenarios. The primary research consists of a large volume of short-term controlled trials where researchers monitored patient-reported outcomes describing perceived discomfort over short time intervals. Findings describe patterns observed in the studies related to patient-reported outcomes describing perceived discomfort when symptoms became more noticeable. However, evidence quality varies across studies when moving beyond acute pain models, and evidence is limited or mixed for certain types of persistent discomfort.

2. Evidence for Management and Reduction of Fever

The medicine was evaluated in numerous trials focusing on outcomes monitoring physiological strain or stress, specifically high body temperature (fever). Most of this research explored short-term symptom changes, primarily by monitoring the patient's temperature over defined time intervals. Research describes patterns related to physiological strain or stress. Comparative reports with other antipyretics occasionally described minor differences in the magnitude or duration of observed changes, though these differences varied between studies. Follow-up durations were limited, and data are still emerging regarding the long-term functional outcomes related to fever management.

3. Studies in Special Populations and Specific Groups

Research has specifically examined the medicine's role in pediatric patients (infants, children, and adolescents). For pregnant individuals, the evidence base primarily consists of observational cohort studies. These studies were observed in some studies to show an association with specific outcomes, but evidence remains limited, and certainty remains low regarding causality. Official sources note that studies examined the use in research contexts involving fluctuating or unstable symptoms in this population. Subgroup findings are uncertain for some populations where sample sizes were modest.

4. Long-Term Evidence and Durability of Response

Clinical trials focus on acute relief, meaning follow-up durations were limited. Long-term information comes from observational settings evaluating daily-life functioning and large-scale public health data. This research was used in research exploring how symptoms evolve in the observed populations and how the medicine was observed to be utilized in the general population. Long-term effects are not fully established by high-certainty randomized controlled trials.

Key Studies & References

  1. Acetaminophen: Uses, Dosage, Side Effects, Warnings - Drugs.com (Comprehensive Drug Monograph)
  2. Acetaminophen: MedlinePlus Drug Information (NIH/NLM)
  3. Revised Guidance Document: Acetaminophen Labelling Standard - Health Canada

Frequently Asked Questions (FAQ)

Common questions about Setopen (FAQ)


Q: Does Setopen affect driving or operating machinery?

Official labeling includes cautions regarding side effects that may affect a person's ability to drive or operate machinery. Adverse reactions such as dizziness and somnolence (feeling tired or drowsy) are listed in the official product information. Official labeling states that awareness of these side effects is important before engaging in activities that require full attention.


Q: Can Setopen be used by older adults?

According to official documents, no overall differences in safety or effectiveness have been specifically observed in the geriatric population when compared to younger adults. The findings indicate that no special dosage or administration adjustments are needed for this population.


Q: Is Setopen addictive or habit-forming?

Setopen, which contains the active ingredient acetaminophen, is generally not considered an addictive or habit-forming substance. It is a non-opioid medicine and is not classified as a controlled drug by regulatory bodies.


Q: What research is available on using Setopen during pregnancy or breastfeeding?

Official regulatory sources generally permit the use of the medicine during pregnancy and lactation if clinically necessary, recommending the lowest effective dose for the shortest possible duration. Regulatory authorities periodically review evidence regarding use during pregnancy and may update labeling as new data emerge.


Q: Is Setopen the same kind of drug as [Similar Drug Name]?

Setopen belongs to the pharmacological class of analgesics and antipyretics. It is defined as a non-opioid medicine whose function is primarily centered on relieving pain and reducing fever.


Q: Is Setopen a new medicine or has it been around for a while?

The active ingredient in Setopen, Acetaminophen, is not a new compound. It was first commercially introduced in the late 19th century and has a long history of use and regulatory approval across the world.


Q: Does Setopen work right away or does it take time?

According to regulatory pharmacokinetics data, oral forms of the medicine are rapidly absorbed into the body. Peak concentrations in the bloodstream are typically achieved within 30 to 60 minutes after administration.


Q: How long can I expect the effect of Setopen to last?

The required dosing interval for immediate-release forms is generally every 4 to 6 hours. This interval reflects the typical duration of time over which a patient can expect to experience symptomatic relief from a single dose.


Q: Is it common to feel tired when starting Setopen?

Feeling tired or drowsy, officially called somnolence, is listed as a common side effect in the official safety documents. The incidence of this reaction is documented as being higher during the first two weeks after starting treatment.


Q: Are there any side effects that happen often with Setopen?

Official safety documents classify common reactions as those occurring in 1 out of 100 to less than 1 out of 10 patients. Examples of these commonly reported reactions include headache, diarrhoea, and somnolence.


Q: Does Setopen interact with common over-the-counter pain relievers?

Official warnings advise against combining Setopen with other over-the-counter pain relievers that also contain acetaminophen. This is noted as an important practice to prevent exceeding the maximum daily dose and risking hepatotoxicity (liver injury).


Q: Are there any interactions with herbal remedies I should know about?

Official patient information advises users to inform their healthcare professional about all herbal products and supplements being taken. Official guidance emphasizes the importance of a complete review of all products being taken.


Q: Is it safe to use Setopen with multivitamins or supplements?

Regulatory guidance suggests that all multivitamins and supplements should be discussed with a healthcare provider. The purpose of this consultation is to confirm if they may affect the safety profile of Setopen.


Q: What happens if I miss a planned use of Setopen?

Regulatory guidance advises that a missed dose should be taken as soon as remembered. However, if the time for the next scheduled dose is quickly approaching, the missed dose should be skipped entirely. Regulatory guidance advises that a double dose should not be taken.


Q: Can Setopen be used for conditions not listed in its main uses?

Setopen is officially approved and labeled for use in the relief of mild-to-moderate pain and the reduction of fever. Official product information specifies that use should align with the approved indications.


Q: Does Setopen have an official patient support program?

While a specific brand program may not be listed in regulatory documents, governmental bodies advise patients to utilize resources from the FDA-supported Acetaminophen Awareness Coalition. This resource provides information for the safe use of the active ingredient.


Q: Can Setopen affect laboratory blood tests?

Official information notes that Setopen can affect the results of certain laboratory blood tests. This includes tests that measure blood glucose and certain liver function enzyme levels.


Q: Have there been any major changes to the official labeling of Setopen recently?

Regulatory agencies periodically review and update labeling information. For instance, the FDA recently initiated a process to update labeling concerning potential risks observed in studies on acetaminophen use during pregnancy.


Q: Can lifestyle factors like diet and exercise influence how Setopen works?

Official eligibility criteria note that use requires caution and is conditional in patients with chronic alcoholism or chronic malnutrition. This indicates that caution is advised when these conditions are present, as they may impact safe use.


Q: Is there a generic version of Setopen available?

Yes, Setopen contains the active ingredient acetaminophen. Generic versions containing this same active ingredient are widely available in various dosage forms.


Q: Do children use Setopen for the same reasons as adults?

Setopen is officially approved for use in children for the same core indications as adults. These primary uses are the relief of pain and the reduction of fever.


Q: Does Setopen have a risk evaluation and mitigation strategy (REMS)?

As a single-ingredient acetaminophen product, Setopen is not currently subject to a specific Risk Evaluation and Mitigation Strategy (REMS) program from the FDA.


Q: What are the common signs of an interaction when taking Setopen with another drug?

Signs of an interaction depend on the drug involved. Common signs can include increased sedation and drowsiness. More serious, though rare, interactions may present with symptoms like confusion, agitation, or muscle twitching (signs of Serotonin Syndrome).


Q: Can Setopen cause trouble concentrating?

Official safety documents list central nervous system effects such as somnolence and dizziness. These effects may be related to feelings of difficulty concentrating.

How should Setopen be stored and disposed of?

Storage and Disposal Requirements

Setopen must be stored in strict accordance with official regulatory requirements to maintain its stability and ensure safety. The medicine must be kept at controlled room temperature, specifically 20 C to 25 C, and protected from excessive heat and moisture.

It is mandatory to store the medicine in its original container with the lid tightly closed.

Storage Restriction Requirement
Temperature Do not exceed 30 C; Do not freeze
Container Keep in original, tightly closed container
Safety Keep out of the sight and reach of children

For disposal, unused or expired Setopen must be returned via a drug take-back program. If this is unavailable, it may be mixed with an undesirable substance, sealed, and placed in the household trash. The medicine must not be flushed down the toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Setopen found in:

A-Z Index: